Table 1 Pathological results of the breast NML
Pathological diagnosis | Number(%) | |
|---|---|---|
Malignant or precursor | N = 62 (100) | |
Invasive carcinoma (non-special type)(B5) | 27 (43.5) | |
Multiform lobular carcinoma(B5) | 1 (1.6) | |
multiform invasive lobular carcinoma(B5) | 1 (1.6) | |
ductal carcinoma(B3) | 30 (48.4) | |
Solid papillary carcinoma(B3) | 3 (4.8) | |
Benign | (B2) | N = 104 (100) |
Hyperplasia without calcification | 18 (17.3) | |
Hyperplasia with calcification | 23 (22.1) | |
Sclerosing adenosis | 5 (4.8) | |
Sclerosing adenosis with calcification | 8 (7.7) | |
Radial scar with calcification | 1 (1.0) | |
Papilloma | 7 (6.7) | |
Papilloma with calcification | 2 (1.9) | |
Adenomatous hyperplasia | 5 (4.8) | |
Adenomatous hyperplasia with calcification | 6 (5.8) | |
Stromal pseudoangiomatous hyperplasia | 1(1.0) | |
Ibroadenoma with calcification | 1 (1.0) | |
Adenosis with infection and calcification | 1 (1.0) | |
Hyperplasia with apocrine metaplasia and calcification | 4 (3.8) | |
ADH | 2 (1.9) | |
ADH with calcification | 5 (4.8) | |
FEA | 3 (2.9) | |
FEA with calcification | 3 (2.9) | |
ADH with papilloma and calcification | 2 (0.2) | |
Benign after 2-years follow-up | 7 (6.7) |